Healthcare resource use and medical costs for the management of oesophageal cancer

Gordon, Louisa G.; Eckermann, Simon; Hirst, Nick; Watson, David I.; Mayne, George C.; Fahey, Paul; Whiteman, David C.

doi:10.1002/bjs.7599

Cited by 19 publications

(15 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the past, ESCC was diagnosed in more advanced stages requiring esophagectomy, which has higher costs than early detection and surveillance of ESCC [12]. With the use of chromoendoscopy and the newer imaging modalities, it is possible to detect earlier ESCC lesions that frequently looked normal using WLE.…”

Section: Discussionmentioning

confidence: 99%

A Case of Esophageal Squamous Cell Cancer in an Endoscopically Normal Esophagus

Khan

2014

J Med Cases

View full text Add to dashboard Cite

Esophageal squamous cell carcinoma (ESCC) has traditionally been detected in the later stages of disease which requires aggressive treatment. Newer endoscopic methods have allowed gastroenterologists to detect ESCC lesions and start treatment earlier with the hope to avoid more difficult treatments such as esophagectomy, chemotherapy and radiation. This report follows a patient from detection of ESCC through successful treatment of the ESCC lesions.

show abstract

Section: Discussionmentioning

confidence: 99%

A Case of Esophageal Squamous Cell Cancer in an Endoscopically Normal Esophagus

Khan

2014

J Med Cases

View full text Add to dashboard Cite

show abstract

“…Healthcare resource use in oesophageal cancer patients is potentially high due to the complex needs of patients during their disease and treatment process with a high number of diagnostic and monitoring investigations frequently performed (Soni & Sonnenberg ; Gordon et al . ). Despite this, detailed descriptions of the costs and/or predictors of costs in oesophageal cancer are limited (Soni & Sonnenberg ; Bachman et al .…”

Section: Introductionmentioning

confidence: 97%

“…; Gordon et al . ). Given the insights such studies may provide policy makers both on the economic burden of the disease and how this might change as disease prevalence changes, this is perhaps surprising.…”

Section: Introductionmentioning

confidence: 97%

“…Work by Gordon et al . () that highlights variation in cost related to stage at diagnosis also warrants closer examination. Here healthcare resource use of oesophageal cancer patients from date of diagnosis to date of death or last date of follow‐up demonstrated lower costs in patients presenting with stage I disease compared with those diagnosed with advanced disease.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Description and predictors of hospital costs of oesophageal cancer during the first year following diagnosis in Northern Ireland

Agus¹,

Kinnear

O’Neill

et al. 2013

Eur J Cancer Care (Engl)

View full text Add to dashboard Cite

The cost-effectiveness of novel interventions in the treatment of cancer is well researched; however, relatively little attention is paid to the cost of many aspects of routine care. Oesophageal cancer is the ninth most common cancer in the UK and sixth most common cause of cancer death. It usually presents late and has a poor prognosis. The hospital costs incurred by oesophageal cancer patients diagnosed in Northern Ireland in 2005 (n = 198) were determined by review of medical records. The average cost of hospital care per patient in the 12 months from presentation was £7847. Variations in total hospital costs by age at diagnosis, gender, cancer stage, histological type, mortality at 1 year, co-morbidity count and socio-economic status were analysed using multiple regression analyses. Higher costs were associated with earlier stages of cancer and cancer stage remained a significant predictor of costs after controlling for cancer type, patient age and mortality at 1 year. Thus, although early detection of cancer usually improves survival, this would mean increased costs in the first year. Deprivation achieved borderline significance with those from more deprived areas having lower resource consumption relative to the more affluent.

show abstract

“…[7,8,9,10] In-hospitalisation results in the greatest cost allocation for diseases in general. [7] Length of stay at the time of surgery is obviously longer for patients with complications,[11,12] but any influence of early postoperative complications on healthcare utilisation from a longer-term perspective is unknown. Therefore, the main aim of this study was to assess the influence of early major postoperative complications after oesophagectomy for cancer on postoperative healthcare utilisation 1 to 5 years after surgery by using a prospective population-based cohort, taking into account any influence of major patient and tumour characteristics.…”

Section: Introductionmentioning

confidence: 99%

Early Complications Following Oesophagectomy for Cancer in Relation to Long-Term Healthcare Utilisation: A Prospective Population-Based Cohort Study

et al. 2015

View full text Add to dashboard Cite

BackgroundLittle is known about how early postoperative complications after oesophagectomy for cancer influence healthcare utilisation in the long-term. We hypothesised that these complications also increase healthcare utilisation long after the recovery period.MethodsThis was a prospective, nationwide Swedish population-based cohort study of patients who underwent curatively intended oesophagectomy for cancer in 2001-2005 and survived at least 1 year postoperatively (n = 390). Total days of in-hospitalisation, number of hospitalisations and number of visits to the outpatient clinic within 5 years of surgery were analysed using quasi-Poisson models with adjustment for patient, tumour and treatment characteristics and are expressed as incidence rate ratios (IRR) and 95% confidence intervals (CI).ResultsThere was an increased in-hospitalisation period 1-5 years after surgery in patients with more than 1 complication (IRR 1.5, 95% CI 1.0-2.4). The IRR for the number of hospitalisations by number of complications was 1.1 (95% CI 0.7-1.6), and 1.2 (95% CI 0.9-1.6) for number of outpatient visits in patients with more than 1 complication. The IRR for in-hospitalisation period 1-5 years following oesophagectomy was 1.8 (95% CI 1.0-3.0) for patients with anastomotic insufficiency and 1.5 (95% CI 0.9-2.5) for patients with cardiovascular or cerebrovascular complications. We found no association with number of hospitalisations (IRR 1.2, 95% CI 0.7-2.0) or number of outpatient visits (IRR 1.3, 95% CI 0.9-1.7) after anastomotic insufficiency, or after cardiovascular or cerebrovascular complications (IRR 1.2, 95% CI 0.7-1.9) and (IRR 1.1, 95% CI 0.8-1.5) respectively.ConclusionThis study showed an increased total in-hospitalisation period 1-5 years after oesophagectomy for cancer in patients with postoperative complications, particularly following anastomotic insufficiency.

show abstract

Healthcare resource use and medical costs for the management of oesophageal cancer

Cited by 19 publications

References 23 publications

A Case of Esophageal Squamous Cell Cancer in an Endoscopically Normal Esophagus

A Case of Esophageal Squamous Cell Cancer in an Endoscopically Normal Esophagus

Description and predictors of hospital costs of oesophageal cancer during the first year following diagnosis in Northern Ireland

Early Complications Following Oesophagectomy for Cancer in Relation to Long-Term Healthcare Utilisation: A Prospective Population-Based Cohort Study

Contact Info

Product

Resources

About